• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝脏浸润性辅助性T细胞产生的白细胞介素-17(IL-17)和白细胞介素-22(IL-22)之间的平衡对小鼠非酒精性脂肪性肝炎(NASH)的发展起着关键的控制作用。

The balance between IL-17 and IL-22 produced by liver-infiltrating T-helper cells critically controls NASH development in mice.

作者信息

Rolla Simona, Alchera Elisa, Imarisio Chiara, Bardina Valentina, Valente Guido, Cappello Paola, Mombello Cristina, Follenzi Antonia, Novelli Francesco, Carini Rita

机构信息

Center for Experimental Research and Medical Studies (CERMS), Azienda Ospedaliera Città della Salute e della Scienza di Torino, via Cherasco 15, 10126 Turin, Italy Department of Molecular Biotechnology and Health Sciences, via Nizza 56, University of Torino, 10126 Turin, Italy.

Department of Health Sciences, University of Piemonte Orientale, via Solaroli 17, 28100 Novara, Italy.

出版信息

Clin Sci (Lond). 2016 Feb;130(3):193-203. doi: 10.1042/CS20150405. Epub 2015 Nov 11.

DOI:10.1042/CS20150405
PMID:26558403
Abstract

The mechanisms responsible for the evolution of steatosis towards NASH (non-alcoholic steatohepatitis) and fibrosis are not completely defined. In the present study we evaluated the role of CD4(+) T-helper (Th) cells in this process. We analysed the infiltration of different subsets of CD4(+) Th cells in C57BL/6 mice fed on a MCD (methionine choline-deficient) diet, which is a model reproducing all phases of human NASH progression. There was an increase in Th17 cells at the beginning of NASH development and at the NASH-fibrosis transition, whereas levels of Th22 cells peaked between the first and the second expansion of Th17 cells. An increase in the production of IL (interleukin)-6, TNFα (tumour necrosis factor α), TGFβ (transforming growth factor β) and CCL20 (CC chemokine ligand 20) accompanied the changes in Th17/Th22 cells. Livers of IL-17(-/-) mice were protected from NASH development and characterized by an extensive infiltration of Th22 cells. In vitro, IL-17 exacerbated the JNK (c-Jun N-terminal kinase)-dependent mouse hepatocyte lipotoxicity induced by palmitate. IL-22 prevented lipotoxicity through PI3K (phosphoinositide 3-kinase)-mediated inhibition of JNK, but did not play a protective role in the presence of IL-17, which up-regulated the PI3K/Akt inhibitor PTEN (phosphatase and tensin homologue deleted on chromosome 10). Consistently, livers of IL-17(-/-) mice fed on the MCD diet displayed decreased activation of JNK, reduced expression of PTEN and increased phosphorylation of Akt compared with livers of wild-type mice. Hepatic infiltration of Th17 cells is critical for NASH initiation and development of fibrosis in mice, and reflects an infiltration of Th22 cells. Th22 cells are protective in NASH, but only in the absence of IL-17. These data strongly support the potentiality of clinical applications of IL-17 inhibitors that can prevent NASH by both abolishing the lipotoxic action of IL-17 and allowing IL-22-mediated protection.

摘要

导致脂肪变性向非酒精性脂肪性肝炎(NASH)和肝纤维化演变的机制尚未完全明确。在本研究中,我们评估了CD4(+)辅助性T(Th)细胞在这一过程中的作用。我们分析了喂食蛋氨酸胆碱缺乏(MCD)饮食的C57BL/6小鼠中不同CD4(+) Th细胞亚群的浸润情况,MCD饮食是一种可重现人类NASH进展各阶段的模型。在NASH发展初期和NASH-肝纤维化转变期,Th17细胞数量增加,而Th22细胞水平在Th17细胞的第一次和第二次扩增之间达到峰值。Th17/Th22细胞变化的同时,白细胞介素(IL)-6、肿瘤坏死因子α(TNFα)、转化生长因子β(TGFβ)和CC趋化因子配体20(CCL20)的产生也增加。IL-17基因敲除小鼠的肝脏可免受NASH发展的影响,其特征是Th22细胞广泛浸润。在体外,IL-17加剧了棕榈酸诱导的依赖c-Jun氨基末端激酶(JNK)的小鼠肝细胞脂肪毒性。IL-22通过磷脂酰肌醇3激酶(PI3K)介导的JNK抑制作用预防脂肪毒性,但在存在IL-17的情况下不发挥保护作用,因为IL-17会上调PI3K/Akt抑制剂第10号染色体缺失的磷酸酶和张力蛋白同源物(PTEN)。同样,与野生型小鼠的肝脏相比,喂食MCD饮食的IL-17基因敲除小鼠的肝脏中JNK活化降低,PTEN表达减少,Akt磷酸化增加。Th17细胞的肝脏浸润对于小鼠NASH的起始和肝纤维化发展至关重要,并反映了Th22细胞的浸润情况。Th22细胞在NASH中具有保护作用,但仅在不存在IL-17的情况下。这些数据有力地支持了IL-17抑制剂临床应用的潜力,其可通过消除IL-17的脂肪毒性作用和允许IL-22介导的保护作用来预防NASH。

相似文献

1
The balance between IL-17 and IL-22 produced by liver-infiltrating T-helper cells critically controls NASH development in mice.肝脏浸润性辅助性T细胞产生的白细胞介素-17(IL-17)和白细胞介素-22(IL-22)之间的平衡对小鼠非酒精性脂肪性肝炎(NASH)的发展起着关键的控制作用。
Clin Sci (Lond). 2016 Feb;130(3):193-203. doi: 10.1042/CS20150405. Epub 2015 Nov 11.
2
Adenosine A2a receptor stimulation blocks development of nonalcoholic steatohepatitis in mice by multilevel inhibition of signals that cause immunolipotoxicity.腺苷A2a受体刺激通过对导致免疫脂毒性的信号进行多级抑制,阻止小鼠非酒精性脂肪性肝炎的发展。
Transl Res. 2017 Apr;182:75-87. doi: 10.1016/j.trsl.2016.11.009. Epub 2016 Dec 6.
3
NF-κB1 deficiency stimulates the progression of non-alcoholic steatohepatitis (NASH) in mice by promoting NKT-cell-mediated responses.NF-κB1 缺乏通过促进 NKT 细胞介导的反应来刺激非酒精性脂肪性肝炎 (NASH) 在小鼠中的进展。
Clin Sci (Lond). 2013 Feb;124(4):279-87. doi: 10.1042/CS20120289.
4
3, 3'-Diindolylmethane alleviates steatosis and the progression of NASH partly through shifting the imbalance of Treg/Th17 cells to Treg dominance.3,3'-二吲哚甲烷通过部分纠正调节性T细胞/辅助性T细胞17的失衡,使其向调节性T细胞占主导地位转变,从而减轻脂肪变性和非酒精性脂肪性肝炎的进展。
Int Immunopharmacol. 2014 Dec;23(2):489-98. doi: 10.1016/j.intimp.2014.09.024. Epub 2014 Oct 1.
5
Interleukin-17 exacerbates hepatic steatosis and inflammation in non-alcoholic fatty liver disease.白细胞介素-17 加剧非酒精性脂肪性肝病中的肝脂肪变性和炎症。
Clin Exp Immunol. 2011 Nov;166(2):281-90. doi: 10.1111/j.1365-2249.2011.04471.x.
6
Adenosine A(2a) receptor stimulation prevents hepatocyte lipotoxicity and non-alcoholic steatohepatitis (NASH) in rats.腺苷 A(2a)受体刺激可预防大鼠肝细胞脂肪毒性和非酒精性脂肪性肝炎(NASH)。
Clin Sci (Lond). 2012 Sep;123(5):323-32. doi: 10.1042/CS20110504.
7
Bias in macrophage activation pattern influences non-alcoholic steatohepatitis (NASH) in mice.巨噬细胞激活模式的偏倚影响小鼠的非酒精性脂肪性肝炎(NASH)。
Clin Sci (Lond). 2012 Jun;122(11):545-53. doi: 10.1042/CS20110366.
8
Adaptive immune responses triggered by oxidative stress contribute to hepatic inflammation in NASH.氧化应激引发的适应性免疫反应有助于 NASH 的肝炎症。
Hepatology. 2014 Mar;59(3):886-97. doi: 10.1002/hep.26749. Epub 2014 Jan 16.
9
Fat-laden macrophages modulate lobular inflammation in nonalcoholic steatohepatitis (NASH).富含脂肪的巨噬细胞调节非酒精性脂肪性肝炎(NASH)中的小叶炎症。
Exp Mol Pathol. 2015 Aug;99(1):155-62. doi: 10.1016/j.yexmp.2015.06.015. Epub 2015 Jun 22.
10
Progression from Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis Is Marked by a Higher Frequency of Th17 Cells in the Liver and an Increased Th17/Resting Regulatory T Cell Ratio in Peripheral Blood and in the Liver.从非酒精性脂肪肝进展为非酒精性脂肪性肝炎的特征是肝脏中Th17细胞频率更高,以及外周血和肝脏中Th17/静息调节性T细胞比例增加。
J Immunol. 2016 Jan 1;196(1):97-105. doi: 10.4049/jimmunol.1501175. Epub 2015 Nov 30.

引用本文的文献

1
Liver immunology: Biological role and clinical significance.肝脏免疫学:生物学作用及临床意义。
World J Hepatol. 2025 Jul 27;17(7):107541. doi: 10.4254/wjh.v17.i7.107541.
2
Inflammation in MASLD progression and cancer.非酒精性脂肪性肝病进展与癌症中的炎症
JHEP Rep. 2025 Apr 2;7(8):101414. doi: 10.1016/j.jhepr.2025.101414. eCollection 2025 Aug.
3
The impact of T cells on immune-related liver diseases: an overview.T细胞对免疫相关性肝病的影响:综述
Inflamm Regen. 2025 Jul 4;45(1):21. doi: 10.1186/s41232-025-00387-0.
4
The microenvironment in the development of MASLD-MASH-HCC and associated therapeutic in MASH-HCC.代谢相关脂肪性肝病-代谢相关脂肪性肝炎-肝细胞癌(MASLD-MASH-HCC)发生发展中的微环境及MASH-HCC的相关治疗
Front Immunol. 2025 Apr 30;16:1569915. doi: 10.3389/fimmu.2025.1569915. eCollection 2025.
5
The role of the interleukin family in liver fibrosis.白细胞介素家族在肝纤维化中的作用。
Front Immunol. 2025 Feb 10;16:1497095. doi: 10.3389/fimmu.2025.1497095. eCollection 2025.
6
Examination of the causal role of immune cells in non-alcoholic fatty liver disease by a bidirectional Mendelian randomization study.通过双向孟德尔随机化研究探讨免疫细胞在非酒精性脂肪性肝病中的因果作用。
Open Med (Wars). 2025 Feb 19;20(1):20251154. doi: 10.1515/med-2025-1154. eCollection 2025.
7
Bile acid activated receptors: Integrating immune and metabolic regulation in non-alcoholic fatty liver disease.胆汁酸激活受体:整合非酒精性脂肪性肝病中的免疫与代谢调节
Liver Res. 2021 Sep 2;5(3):119-141. doi: 10.1016/j.livres.2021.08.003. eCollection 2021 Sep.
8
Metabolism of hepatic stellate cells in chronic liver diseases: emerging molecular and therapeutic interventions.慢性肝病中肝星状细胞的代谢:新出现的分子和治疗干预措施。
Theranostics. 2025 Jan 2;15(5):1715-1740. doi: 10.7150/thno.106597. eCollection 2025.
9
Immunology and treatments of fatty liver disease.脂肪肝疾病的免疫学与治疗方法
Arch Toxicol. 2025 Jan;99(1):127-152. doi: 10.1007/s00204-024-03920-1. Epub 2024 Dec 18.
10
Role of the type 3 cytokines IL-17 and IL-22 in modulating metabolic dysfunction-associated steatotic liver disease.细胞因子 IL-17 和 IL-22 在调节代谢相关脂肪性肝病中的作用。
Front Immunol. 2024 Aug 2;15:1437046. doi: 10.3389/fimmu.2024.1437046. eCollection 2024.